(Q42485217)

English

The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma

scientific article published on 7 March 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

author name string

M G Castagna

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

H P Tala Jury

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

C Cipri

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

V Belardini

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

C Fioravanti

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

L Pasqui

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

F Sestini

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

A Theodoropoulou

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

F Pacini

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

7 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

e219-23

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of the predictive value model in the analysis of test effectiveness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine the

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Post-surgical follow-up of differentiated thyroid cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum thyroglobulin in thyroid carcinoma and other thyroid disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21399390

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42485217&oldid=2205437091"